Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tessa Romero's Stock Ratings
JP Morgan Analyst
Tessa Romero is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/20/2025
Overall Average Return
11.3%
Smart Score
Overall Average Return Percentile
64th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/18/2025 | BHVN | Buy Now | Biohaven | $14.51 | 279.05% | Tessa Romero60% | $68 → $55 | Maintains | Overweight | Get Alert |
| 06/09/2025 | CYTK | Buy Now | Cytokinetics | $32.51 | 63.03% | Tessa Romero60% | $71 → $53 | Maintains | Overweight | Get Alert |
| 06/06/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.76 | 31.81% | Tessa Romero60% | $26 → $30 | Maintains | Overweight | Get Alert |
| 05/30/2025 | LXEO | Buy Now | Lexeo Therapeutics | $3.84 | 160.42% | Tessa Romero60% | $16 → $10 | Maintains | Overweight | Get Alert |
| 03/21/2025 | DYN | Buy Now | Dyne Therapeutics | $10.29 | 65.21% | Tessa Romero60% | $18 → $17 | Maintains | Neutral | Get Alert |
| 03/05/2025 | BHVN | Buy Now | Biohaven | $14.51 | 368.64% | Tessa Romero60% | $72 → $68 | Maintains | Overweight | Get Alert |
| 11/05/2024 | UPB | Buy Now | Upstream Bio | $10.77 | 252.83% | Tessa Romero60% | → $38 | Initiates | → Overweight | Get Alert |
| 11/05/2024 | NMRA | Buy Now | Neumora Therapeutics | $0.77 | 1845.27% | Tessa Romero60% | $18 → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 10/24/2024 | DYN | Buy Now | Dyne Therapeutics | $10.29 | 240.14% | Tessa Romero60% | $43 → $35 | Downgrade | Overweight → Neutral | Get Alert |
| 10/24/2024 | MCRB | Buy Now | Seres Therapeutics | $7.53 | — | Tessa Romero60% | — | Downgrade | Neutral → Underweight | Get Alert |
| 10/14/2024 | SRRK | Buy Now | Scholar Rock Holding | $34.08 | -9.04% | Tessa Romero60% | $18 → $31 | Maintains | Overweight | Get Alert |
| 10/03/2024 | SRRK | Buy Now | Scholar Rock Holding | $34.08 | -47.18% | Tessa Romero60% | $20 → $18 | Maintains | Overweight | Get Alert |
| 10/03/2024 | BHVN | Buy Now | Biohaven | $14.51 | 368.64% | Tessa Romero60% | $55 → $68 | Maintains | Overweight | Get Alert |
| 09/05/2024 | CYTK | Buy Now | Cytokinetics | $32.51 | 118.39% | Tessa Romero60% | $65 → $71 | Maintains | Overweight | Get Alert |
| 08/13/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.47 | 242.38% | Tessa Romero60% | $32 → $29 | Maintains | Overweight | Get Alert |
| 08/12/2024 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 117.77% | Tessa Romero60% | $30 → $31 | Maintains | Overweight | Get Alert |
| 07/09/2024 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 110.75% | Tessa Romero60% | $27 → $30 | Maintains | Overweight | Get Alert |
| 07/09/2024 | DYN | Buy Now | Dyne Therapeutics | $10.29 | 317.88% | Tessa Romero60% | $39 → $43 | Maintains | Overweight | Get Alert |
| 06/24/2024 | CYTK | Buy Now | Cytokinetics | $32.51 | 99.94% | Tessa Romero60% | $77 → $65 | Maintains | Overweight | Get Alert |
| 06/13/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $36.50 | 26.03% | Tessa Romero60% | → $46 | Reinstates | Neutral → Neutral | Get Alert |
| 06/04/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.47 | 277.8% | Tessa Romero60% | $35 → $32 | Maintains | Overweight | Get Alert |
| 03/25/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.76 | 9.84% | Tessa Romero60% | $29 → $25 | Maintains | Overweight | Get Alert |
| 03/18/2024 | NMRA | Buy Now | Neumora Therapeutics | $0.77 | 2753.07% | Tessa Romero60% | $20 → $22 | Maintains | Overweight | Get Alert |
| 03/07/2024 | CYTK | Buy Now | Cytokinetics | $32.51 | 136.85% | Tessa Romero60% | $78 → $77 | Maintains | Overweight | Get Alert |
| 03/01/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.76 | 27.42% | Tessa Romero60% | $32 → $29 | Maintains | Overweight | Get Alert |
| 02/23/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $36.50 | -17.81% | Tessa Romero60% | $31 → $30 | Maintains | Neutral | Get Alert |
| 02/23/2024 | BHVN | Buy Now | Biohaven | $14.51 | 285.94% | Tessa Romero60% | $32 → $56 | Maintains | Overweight | Get Alert |
| 01/23/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $36.50 | -15.07% | Tessa Romero60% | $30 → $31 | Maintains | Neutral | Get Alert |
| 01/22/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.47 | 313.22% | Tessa Romero60% | → $35 | Initiates | → Overweight | Get Alert |
| 11/28/2023 | LXEO | Buy Now | Lexeo Therapeutics | $3.84 | 420.83% | Tessa Romero60% | → $20 | Initiates | → Overweight | Get Alert |
| 11/20/2023 | BHVN | Buy Now | Biohaven | $14.51 | 120.54% | Tessa Romero60% | $26 → $32 | Maintains | Overweight | Get Alert |
| 11/08/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $36.50 | -17.81% | Tessa Romero60% | $32 → $30 | Maintains | Neutral | Get Alert |
| 11/08/2023 | NMRA | Buy Now | Neumora Therapeutics | $0.77 | 2493.7% | Tessa Romero60% | $21 → $20 | Maintains | Overweight | Get Alert |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $0.77 | 2623.38% | Tessa Romero60% | → $21 | Initiates | → Overweight | Get Alert |
| 10/10/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.76 | 40.6% | Tessa Romero60% | $29 → $32 | Upgrade | Neutral → Overweight | Get Alert |
| 08/22/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.63 | 51.19% | Tessa Romero60% | $8 → $7 | Maintains | Underweight | Get Alert |
| 08/16/2023 | BHVN | Buy Now | Biohaven | $14.51 | 65.4% | Tessa Romero60% | $27 → $24 | Maintains | Overweight | Get Alert |
| 08/09/2023 | DYN | Buy Now | Dyne Therapeutics | $10.29 | 113.8% | Tessa Romero60% | $20 → $22 | Maintains | Overweight | Get Alert |
| 08/07/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.76 | 27.42% | Tessa Romero60% | $28 → $29 | Maintains | Neutral | Get Alert |
| 08/07/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $36.50 | -12.33% | Tessa Romero60% | $33 → $32 | Maintains | Neutral | Get Alert |
| 06/30/2023 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 75.62% | Tessa Romero60% | $24 → $25 | Maintains | Overweight | Get Alert |
| 05/16/2023 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 68.6% | Tessa Romero60% | $25 → $24 | Maintains | Overweight | Get Alert |
| 04/25/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $32.24 | 70.6% | Tessa Romero60% | $54 → $55 | Maintains | Overweight | Get Alert |
| 04/21/2023 | MCRB | Buy Now | Seres Therapeutics | $7.53 | -7.04% | Tessa Romero60% | → $7 | Initiates | → Neutral | Get Alert |
| 03/20/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.76 | -7.73% | Tessa Romero60% | $19 → $21 | Maintains | Neutral | Get Alert |
| 03/20/2023 | CYTK | Buy Now | Cytokinetics | $32.51 | 59.95% | Tessa Romero60% | $55 → $52 | Maintains | Overweight | Get Alert |
| 02/28/2023 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 75.62% | Tessa Romero60% | $27 → $25 | Maintains | Overweight | Get Alert |
| 01/04/2023 | BHVN | Buy Now | Biohaven | $14.51 | 58.51% | Tessa Romero60% | → $23 | Initiates | → Overweight | Get Alert |
| 12/01/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $36.50 | -9.59% | Tessa Romero60% | $48 → $33 | Maintains | Neutral | Get Alert |
| 11/29/2022 | DYN | Buy Now | Dyne Therapeutics | $10.29 | 74.93% | Tessa Romero60% | $24 → $18 | Maintains | Overweight | Get Alert |
| 11/18/2022 | SRRK | Buy Now | Scholar Rock Holding | $34.08 | -41.31% | Tessa Romero60% | $38 → $20 | Maintains | Overweight | Get Alert |
| 11/14/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $22.76 | -25.31% | Tessa Romero60% | $19 → $17 | Maintains | Neutral | Get Alert |
| 10/31/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.63 | 51.19% | Tessa Romero60% | $16 → $7 | Downgrade | Neutral → Underweight | Get Alert |
| 07/21/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $32.24 | 70.6% | Tessa Romero60% | → $55 | Initiates | → Overweight | Get Alert |
| 06/28/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Tessa Romero60% | $39 → $36 | Maintains | Neutral | Get Alert |
| 05/24/2022 | SRRK | Buy Now | Scholar Rock Holding | $34.08 | 8.57% | Tessa Romero60% | $46 → $37 | Maintains | Overweight | Get Alert |
| 02/14/2022 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 124.8% | Tessa Romero60% | $33 → $32 | Maintains | Overweight | Get Alert |
| 01/06/2022 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 131.82% | Tessa Romero60% | $30 → $33 | Maintains | Overweight | Get Alert |
| 01/03/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.63 | 483.15% | Tessa Romero60% | $30 → $27 | Maintains | Neutral | Get Alert |
| 11/16/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.63 | 547.95% | Tessa Romero60% | $57 → $30 | Downgrade | Overweight → Neutral | Get Alert |
| 06/28/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | Tessa Romero60% | → $36 | Downgrade | Overweight → Neutral | Get Alert |
| 04/20/2021 | EWTX | Buy Now | Edgewise Therapeutics | $14.23 | 138.85% | Tessa Romero60% | → $34 | Initiates | → Overweight | Get Alert |
| 03/22/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.63 | 1023.11% | Tessa Romero60% | → $52 | Assumes | → Overweight | Get Alert |
| 03/02/2021 | ORTX | Buy Now | Orchard Therapeutics | — | — | Tessa Romero60% | $14 → $15 | Assumes | → Overweight | Get Alert |
| 01/06/2021 | SRRK | Buy Now | Scholar Rock Holding | $34.08 | 73.12% | Tessa Romero60% | → $59 | Initiates | → Overweight | Get Alert |
| 12/17/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | Tessa Romero60% | $58 → $79 | Maintains | Equal-Weight | Get Alert |
| 01/04/2017 | GBT | Buy Now | Global Blood Therapeutics | — | — | Tessa Romero60% | → $25 | Initiates | → Overweight | Get Alert |
